Remarkably, about 25% of Rank/Brca1/p53 triple-mutant mice never developed any breast tumors by around day 400 after birth, whereas all Brca1/p53 double-mutant mice developed tumors by around day 200 [24]. This evidence concerns the gene TP53 and breast neoplasm.